Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.

Background:Invasive mould infections are a significant cause of morbidity and mortality in pediatric cancer patients, particularly in those undergoing aggressive myeloablative chemotherapy. Voriconazole has been described as an appropriate and effective prophylactic agent in adults with cancer.Metho